Labcorp Acquires BioReference Health’s Oncology Testing Assets for $225 Million
The deal includes customer accounts and operating assets focused on cancer-related clinical testing services across the United States.
The deal includes customer accounts and operating assets focused on cancer-related clinical testing services across the United States.
Cancer diagnostics company adds three clinical advisors and two board members to support commercial growth and platform expansion.
Inconsistent use of CFCs—especially around replacement claims—is causing costly inefficiencies in healthcare billing.
COLA Inc. is rebranding as the Commission on Laboratory Accreditation (COLA) to better reflect its mission promoting laboratory excellence.
A federal court ruled in favor of AMP, striking down the FDA’s attempt to regulate laboratory-developed tests (LDTs) as medical devices.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
Quanterix Corporation has completed its acquisition of Akoya Biosciences, expanding its capabilities and market reach.
Scientists have documented a notable case of antibiotic resistance evolving within a critically ill patient during treatment for an E. coli bloodstream infection, providing genomic evidence of how drug resistance can emerge in real time.